series-b
Stage
1
Investors
About
Permanence Bio develops therapeutics that protect the genome by preventing DNA damage, aiming to treat and prevent diseases such as cancer, acute ophthalmological and renal illnesses, and genetic disorders.
Explore Permanence Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.